Clinical trial
Chinese Children's Cancer Group T-cell Acute Lymphoblastic Leukemia -2025 Project
NCT06855810 is registered in ClinicalTrials.gov with Institute of Hematology & Blood Diseases Hospital, China as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Chinese Children's Cancer Group T-cell Acute Lymphoblastic Leukemia -2025 Project
- Lead sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Phase
- Phase 2/3
- Overall status
- Recruiting
- Start date
- March 11, 2025
- Completion date
- June 30, 2031
- Enrollment
- 610 (estimated)
- Sites
- 27
Conditions
As the registry lists them; a condition with its own page is linked.
acute lymphoblastic leukemia, childhood leukemia, acute lymphoblastic, t cell acute lymphoblastic leukemia/lymphoblastic lymphoma